MedTrace Logo

Effect of Pyridoxine on Behavioral Adverse Events of Levetiracetam

NCT05008354 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-03-29

No results posted yet for this study

Summary

This study is a two-arm parallel group randomized double-blind placebo-controlled trial with the aim of Investigating pyridoxine effect on behavioral side effects of levetiracetam in adult patients with epilepsy.

Conditions

Interventions

DRUG

Pyridoxine

Pyridoxine tablet 40mg once daily

DRUG

Placebo

Placebo tablet once daily

Sponsors & Collaborators

  • Mazandaran University of Medical Sciences

    collaborator OTHER

  • Nasim Tabrizi

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-09-01
Completion
2021-09-01

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05008354 on ClinicalTrials.gov